Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Banito

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Cancer Discovery|April 22, 2016
BRD4 Connects Enhancer Remodeling to Senescence Immune SurveillanceNilgun Tasdemir, Ana Banito, Jae-Seok Roe, et al.
The Journal of Clinical Investigation|April 29, 2025
DNA demethylating agents suppress preclinical models of synovial sarcomaNobuhiko Hasegawa, Nezha S Benabdallah, Kyllie Smith-Fry, et al.
Cancer Discovery|June 3, 2021
A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF DestructionJinxiu Li, Timothy S Mulvihill, Li Li, et al.
Cell|August 2, 2014
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancerDarjus F Tschaharganeh, Wen Xue, Diego F Calvisi, et al.
Cell|June 4, 2016
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver CancerDarjus F Tschaharganeh, Wen Xue, Diego F Calvisi, et al.
Elife|June 1, 2023
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancerChangyu Zhu, Yadira M Soto-Feliciano, John P Morris, et al.
Gut|September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancerSteffie Revia, Agnieszka Seretny, Lena Wendler, et al.
NPJ Precision Oncology|June 17, 2026
Integration and validation of complementary ex vivo assays for functional precision oncologyAnna Loboda, Jasmina Paluncic, Micaela Freitas, et al.
Cell Stem Cell|January 10, 2012
MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiationAna O'Loghlen, Ana M Muñoz-Cabello, Alexandre Gaspar-Maia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 14, 2026
Corrigendum to "EPICYCLE: A confirmatory preclinical study of the anti-rhabdomyosarcoma efficacy of BET bromodomain and cyclin-dependent kinase 9 inhibitors" [Biomed. Pharmacother. 192 (2025), 118704]Bernhard Haller, Günther Hs Richter, Marco Wachtel, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Cancer Discovery|April 22, 2016
BRD4 Connects Enhancer Remodeling to Senescence Immune SurveillanceNilgun Tasdemir, Ana Banito, Jae-Seok Roe, et al.
The Journal of Clinical Investigation|April 29, 2025
DNA demethylating agents suppress preclinical models of synovial sarcomaNobuhiko Hasegawa, Nezha S Benabdallah, Kyllie Smith-Fry, et al.
Cancer Discovery|June 3, 2021
A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF DestructionJinxiu Li, Timothy S Mulvihill, Li Li, et al.
Cell|August 2, 2014
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancerDarjus F Tschaharganeh, Wen Xue, Diego F Calvisi, et al.
Cell|June 4, 2016
p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver CancerDarjus F Tschaharganeh, Wen Xue, Diego F Calvisi, et al.
Elife|June 1, 2023
MLL3 regulates the <i>CDKN2A</i> tumor suppressor locus in liver cancerChangyu Zhu, Yadira M Soto-Feliciano, John P Morris, et al.
Gut|September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancerSteffie Revia, Agnieszka Seretny, Lena Wendler, et al.
NPJ Precision Oncology|June 17, 2026
Integration and validation of complementary ex vivo assays for functional precision oncologyAnna Loboda, Jasmina Paluncic, Micaela Freitas, et al.
Cell Stem Cell|January 10, 2012
MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiationAna O'Loghlen, Ana M Muñoz-Cabello, Alexandre Gaspar-Maia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 14, 2026
Corrigendum to "EPICYCLE: A confirmatory preclinical study of the anti-rhabdomyosarcoma efficacy of BET bromodomain and cyclin-dependent kinase 9 inhibitors" [Biomed. Pharmacother. 192 (2025), 118704]Bernhard Haller, Günther Hs Richter, Marco Wachtel, et al.
Pageof 6